Cargando…

Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy

Arrhythmogenic left ventricular cardiomyopathy (ALVC) is a rare heritable heart-muscle disorder characterized by a progressive loss of left ventricular myocardium and its replacement by fibrofatty tissue. Myocarditis is an inflammatory disease of the heart that may occur secondary to infections, imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Alania-Torres, Edgardo, Morillas-Climent, Herminio, García-Escrivá, Alexandre, Vinueza-Buitrón, Paul, Poquet-Catalá, Inmaculada, Zorio, Esther, Sánchez-Lázaro, Ignacio José, Galcerá-Jornet, Emilio, Valle-Muñoz, Alfonso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545905/
https://www.ncbi.nlm.nih.gov/pubmed/34712717
http://dx.doi.org/10.3389/fcvm.2021.759119
_version_ 1784590088674476032
author Alania-Torres, Edgardo
Morillas-Climent, Herminio
García-Escrivá, Alexandre
Vinueza-Buitrón, Paul
Poquet-Catalá, Inmaculada
Zorio, Esther
Sánchez-Lázaro, Ignacio José
Galcerá-Jornet, Emilio
Valle-Muñoz, Alfonso
author_facet Alania-Torres, Edgardo
Morillas-Climent, Herminio
García-Escrivá, Alexandre
Vinueza-Buitrón, Paul
Poquet-Catalá, Inmaculada
Zorio, Esther
Sánchez-Lázaro, Ignacio José
Galcerá-Jornet, Emilio
Valle-Muñoz, Alfonso
author_sort Alania-Torres, Edgardo
collection PubMed
description Arrhythmogenic left ventricular cardiomyopathy (ALVC) is a rare heritable heart-muscle disorder characterized by a progressive loss of left ventricular myocardium and its replacement by fibrofatty tissue. Myocarditis is an inflammatory disease of the heart that may occur secondary to infections, immune system activation or exposure to drugs. Hot phases of ALVC present with chest pain and troponin rise, mimicking acute viral myocarditis and indicate a progression of the disease. Recently, myocarditis has also been described as an infrequent complication of coronavirus disease 2019 (Covid-19) mRNA vaccines. We herein report for the first time a case of probable myocarditis induced by Covid-19 vaccine in a patient with previous medical history of ALVC. We aim to highlight the common characteristics of ALVC and Covid-19 vaccine myocarditis and work through the differential diagnosis of these two entities.
format Online
Article
Text
id pubmed-8545905
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85459052021-10-27 Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy Alania-Torres, Edgardo Morillas-Climent, Herminio García-Escrivá, Alexandre Vinueza-Buitrón, Paul Poquet-Catalá, Inmaculada Zorio, Esther Sánchez-Lázaro, Ignacio José Galcerá-Jornet, Emilio Valle-Muñoz, Alfonso Front Cardiovasc Med Cardiovascular Medicine Arrhythmogenic left ventricular cardiomyopathy (ALVC) is a rare heritable heart-muscle disorder characterized by a progressive loss of left ventricular myocardium and its replacement by fibrofatty tissue. Myocarditis is an inflammatory disease of the heart that may occur secondary to infections, immune system activation or exposure to drugs. Hot phases of ALVC present with chest pain and troponin rise, mimicking acute viral myocarditis and indicate a progression of the disease. Recently, myocarditis has also been described as an infrequent complication of coronavirus disease 2019 (Covid-19) mRNA vaccines. We herein report for the first time a case of probable myocarditis induced by Covid-19 vaccine in a patient with previous medical history of ALVC. We aim to highlight the common characteristics of ALVC and Covid-19 vaccine myocarditis and work through the differential diagnosis of these two entities. Frontiers Media S.A. 2021-10-12 /pmc/articles/PMC8545905/ /pubmed/34712717 http://dx.doi.org/10.3389/fcvm.2021.759119 Text en Copyright © 2021 Alania-Torres, Morillas-Climent, García-Escrivá, Vinueza-Buitrón, Poquet-Catalá, Zorio, Sánchez-Lázaro, Galcerá-Jornet and Valle-Muñoz. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Alania-Torres, Edgardo
Morillas-Climent, Herminio
García-Escrivá, Alexandre
Vinueza-Buitrón, Paul
Poquet-Catalá, Inmaculada
Zorio, Esther
Sánchez-Lázaro, Ignacio José
Galcerá-Jornet, Emilio
Valle-Muñoz, Alfonso
Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy
title Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy
title_full Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy
title_fullStr Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy
title_full_unstemmed Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy
title_short Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy
title_sort case report: probable myocarditis after covid-19 mrna vaccine in a patient with arrhythmogenic left ventricular cardiomyopathy
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545905/
https://www.ncbi.nlm.nih.gov/pubmed/34712717
http://dx.doi.org/10.3389/fcvm.2021.759119
work_keys_str_mv AT alaniatorresedgardo casereportprobablemyocarditisaftercovid19mrnavaccineinapatientwitharrhythmogenicleftventricularcardiomyopathy
AT morillasclimentherminio casereportprobablemyocarditisaftercovid19mrnavaccineinapatientwitharrhythmogenicleftventricularcardiomyopathy
AT garciaescrivaalexandre casereportprobablemyocarditisaftercovid19mrnavaccineinapatientwitharrhythmogenicleftventricularcardiomyopathy
AT vinuezabuitronpaul casereportprobablemyocarditisaftercovid19mrnavaccineinapatientwitharrhythmogenicleftventricularcardiomyopathy
AT poquetcatalainmaculada casereportprobablemyocarditisaftercovid19mrnavaccineinapatientwitharrhythmogenicleftventricularcardiomyopathy
AT zorioesther casereportprobablemyocarditisaftercovid19mrnavaccineinapatientwitharrhythmogenicleftventricularcardiomyopathy
AT sanchezlazaroignaciojose casereportprobablemyocarditisaftercovid19mrnavaccineinapatientwitharrhythmogenicleftventricularcardiomyopathy
AT galcerajornetemilio casereportprobablemyocarditisaftercovid19mrnavaccineinapatientwitharrhythmogenicleftventricularcardiomyopathy
AT vallemunozalfonso casereportprobablemyocarditisaftercovid19mrnavaccineinapatientwitharrhythmogenicleftventricularcardiomyopathy